Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapieAnimalsThalidomideMiceInbred C57BLMale
Apremilast attenuates hepatic steatosis and metabolic dysfunction in a murine model of MASLD: Implications for patients with Psoriatic disease.
Miriam Ruiz-Ponce, Sergio Rodriguez-Cuenca, Jesus Eduardo Martin-Salazar, Carlos Pérez-Sánchez, Julio M Martínez-Moreno, Adrián Llamas-Urbano, Mark Campbell, Laura Romero-Zurita, Maria Dolores López-Montilla, Laura Cuesta-López, Antonio Manuel Barranco, Pedro Ortiz-Buitrago, Chary López-Pedrera, Alejandro Escudero-Contreras, Eduardo Collantes-Estevez
Published: 202510.1016/j.biopha.2025.118757
Abstract
BACKGROUND: Metabolic dysfunction-associated steatotic liver disease (MASLD) is a major cause of morbidity, linked to obesity, type 2 diabetes, and cardiovascular disease. Psoriatic disease (PsD), a chronic inflammatory condition, often coexists with…
Preview only. Read the full abstract at the source